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ABSTRACT The electrogenicNa/Ca exchanger (NCX)
mediates bidirectional Ca movements that are highly sen-
sitive to changes of Na gradients in many cells. NCX1
is implicated in the pathogenesis of heart failure and
a number of cardiac arrhythmias. We measured NCX1
palmitoylation using resin-assisted capture, the subcellular
location of yellow ﬂuorescent protein–NCX1 fusion pro-
teins, andNCX1 currents using whole-cell voltage clamping.
Rat NCX1 is substantially palmitoylated in all tissues exam-
ined. Cysteine 739 in the NCX1 large intracellular loop is
necessary and sufﬁcient for NCX1 palmitoylation. Palmi-
toylationofNCX1occurs in theGolgi andanchors theNCX1
large regulatory intracellular loop to membranes. Surpris-
ingly, palmitoylation does not inﬂuence trafﬁcking or local-
ization of NCX1 to surface membranes, nor does it strongly
affect the normal forward or reverse transport modes of
NCX1. However, exchangers that cannot be palmitoylated
do not inactivate normally (leading to substantial activity in
conditions when wild-type exchangers are inactive) and do
not promote cargo-dependent endocytosis that internalizes
50%of the cell surface following strongG-protein activation
or largeCa transients.Thepalmitoylated cysteine inNCX1 is
found in all vertebrate and some invertebrate NCX homo-
logs. Thus, NCX palmitoylation ubiquitously modulates Ca
homeostasis and membrane domain function in cells that
expressNCXproteins.—Reilly,L.,Howie, J.,Wypijewski,K.,
Ashford,M.L. J.,Hilgemann,D.W.,Fuller,W.Palmitoylation
of the Na/Ca exchanger cytoplasmic loop controls its in-
activationand internalizationduring stress signaling.FASEB J.
29, 4532–4543 (2015). www.fasebj.org
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Cardiac diastole relies on effective removal of Ca from the
cytoplasm of ventricular myocytes to allow relaxation and
reﬁlling of the ventricles. Removal of Ca occurs as a bal-
anced competition between sarcoplasmic reticulum Ca
ATPases (SERCA 2a) and Na/Ca exchangers; Ca pumps
sequester Ca into the sarcoplasmic reticulum, and Na/Ca
exchangers (NCXs) extrude Ca to the extracellular space
(1). In large mammals, SERCA mediates ;70% and NCX
;30%ofCaremoval (2).NCXcanoperate ineither forward
(Ca extrusion) or reverse (Ca inﬂux)modes, depending on
membrane potential, the prevailing Na gradient, and the
subsarcolemmal freeCaconcentration.NCX1splicevariants
are widely expressed in both excitable and nonexcitable tis-
sues, and the NCX1.1 splice variant is the major Na/Ca ex-
changer in cardiac muscle (3). NCX2 and NCX3 are
expressed in brain and skeletal muscle; like NCX1, multiple
splice variants of NCX3 have been identiﬁed (4).
Contractile abnormalities that occur in left ventricular
hypertrophy and failure can be related to an imbalance
between SERCA and NCX. Most commonly, depletion of
intracellular Ca stores occurs because either SERCA activ-
ity is decreased orNCXactivity is increased (5, 6). Currents
generated by NCX, especially when its expression is pro-
moted by cardiac pathologies, can cause arrhythmogenic
delayed after depolarizations (7, 8). In a setting of ische-
mia, or reoxygenation of ischemic tissue, reverse-mode
NCX can generate Ca overload, leading to necrotic myo-
cyte death (9). Abnormal function of NCX is described in
hypertension (10), cerebral ischemia (11), muscular dys-
trophy (12), and diabetes (13). Accordingly, the potential
of NCX as a therapeutic target is relevant to numerous
pathologies besides cardiac pathologies (14–19).
The NCX1 transmembrane architecture consists of
2 inverted repeats, each comprising 5 transmembrane
helices (20, 21). NCX1 is regulated by both ions that it
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transports: a large intracellular loop between TM5 and
TM6 facilitates inactivation by Na (22) and mediates sec-
ondary activation by Ca via 2 Ca binding domains (CBDs)
(23, 24).Both inactivationbyNa[whichdoesnot involve an
interaction with the CBDs (25, 26)] and activation via oc-
cupation of CBDs are stronglymodulated by binding of the
phospholipid PIP2 to cationic sites of the cytoplasmic loop,
dubbed the exchanger inhibitory peptide (XIP) domain:
PIP2 activates NCX mostly by antagonizing Na-dependent
inactivation (27, 28). The functional roles of phosphoryla-
tion of NCX1 remain controversial (29–31), and no dy-
namic posttranslational modiﬁcations are deﬁnitively
established to directly regulate NCX1. NCX regulatory
mechanisms are discussed in detail elsewhere (32).
The reversible acylation of proteins via a thioester bond
between a cysteine sulfhydryl side chain and the fatty acid
palmitate (palmitoylation) commonly regulates membrane
association, subcellular location, trafﬁcking, turnover rate,
and enzymatic activity of both peripheral and integral
membrane proteins (33). The activities of many ion chan-
nels and transporters are regulated by palmitoylation (34).
Here, we report that NCX1 is palmitoylated in ventricular
muscle at a single cysteine in its large intracellular loop.
Palmitoylation does not inﬂuence constitutive NCX1 traf-
ﬁcking, but it is required for the complete inactivation of
NCX1followingchelationofcytoplasmicCaand/oranionic
phospholipids that activate NCX1. In addition, palmitoyla-
tion promotes the participation of NCX1 in membrane
domain (i.e., lipid raft)-dependent endocytosis that can be
activated by G proteins and large Ca transients.
MATERIALS AND METHODS
All experiments involving animals were approved by the Univer-
sity of Dundee Welfare and Ethical Use of Animals Committee.
Materials and antibodies
Anti-NCX1was fromSwant,anti-caveolin3andﬂotillin2were from
BD Biosciences (San Jose, CA, USA), and anti–green ﬂuorescent
proteinwas fromAbcam(Cambridge,MA,USA).Themonoclonal
antibody a6F raised against the sodium pump a1 subunit by
Douglas M. Fambrough (Johns Hopkins University, Baltimore,
MD, USA) was obtained from the Developmental Studies Hy-
bridoma Bank developed under the auspices of the Eunice Kennedy
Shriver National Institute of Child Health and Human Develop-
ment (NICHD) and maintained by The University of Iowa, De-
partment of Biology (Iowa City, IA, USA).
Puriﬁcation of palmitoylated proteins
Palmitoylated proteins were puriﬁed using thiopropyl Sepharose
in the presence of neutral hydroxylamine after alkylation of free
thiols with methyl methanethiosulfonate, as described previously
(35).Unfractionated (aftermethylmethanethiosulfonate block),
unbound (not captured by thiopropyl Sepharose in the presence
of hydroxylamine), and acylated (captured by thiopropyl
Sepharose beads) fractions were routinely analyzed to assess de-
pletion of proteins from the unbound fraction and their enrich-
ment in the acylated fraction.
Puriﬁcation of cell surface proteins
Representative fractions of cell surface proteinswere prepared by
brieﬂy treating cells with 1 mg/ml sulfo-NHS-SS-biotin (Pierce,
Rockford, IL, USA) for 10 min at 37°C to biotinylate integral
surface membrane proteins with extracellular primary amines,
which were subsequently puriﬁed using streptavidin Sepharose
(GE Healthcare, Waukesha, WI, USA).
Plasmids, cell lines, and transfection
Canine NCX1.1 cDNA was kindly provided by Professor Godfrey
Smith (University of Glasgow, Glasgow, United Kingdom).
DsRed-ER was from Clontech (Mountain View, CA, USA) and
Grasp65-mCherry was kindly provided by Dr. Jon Lane (Univer-
sity of Bristol, Bristol, United Kingdom). Yellow ﬂuorescent pro-
tein (YFP) NCX1 large intracellular loop (YFP-NCX1-IC) was
created by inserting canineNCX1.1 cDNA(codons 219 to 761) at
the39endof YFP invectorpEFYP-C1(Clontech).All transfections
of plasmid DNA used Lipofectamine 2000 (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions. Human
embryonic kidney (HEK)-derived FT-293 cells expressing tet-
induciblewild-type (WT)andC739ANCX1weregeneratedusing
the Invitrogen Flip-In T-Rex system.
Myocytes
Ca-tolerant adult ventricular myocytes were isolated from the
hearts of maleWistar rats (250–300 g) by retrograde perfusion of
collagenase in the Langendorff mode. Human-induced plu-
ripotent stemcells were differentiated into cardiacmyocytes at
the University of Dundee iPSC facility using established
protocols.
Microscopy
Images were acquired from cells ﬁxed in 4% paraformaldehyde
24 h after transfection using a Leica SP5 confocal microscope.
Acquisition parameters were (excitation/emission, in nano-
meters): YFP, 519/542; DsRed, 575/644; mCherry, 580/700.
Electrophysiology
FT-293 cells were removed from dishes by treatment with trypsin
(0.1%) and were patch clamped (whole-cell conﬁguration) at
37°C with pipette perfusion and fast bath solution exchange and
capacitancemeasurements as described previously (36).Holding
potential was 0 mV, and solutions employed were designed to
minimize all membrane currents not carried by NCX. Solution
compositions are given in Table 1.
Sucrose gradient fractionation
Caveolin-enriched buoyant membranes were prepared from
ventricular myocytes using a discontinuous sucrose gradient as
describedpreviously (37). Followingovernight centrifugation the
uppermost three 1 ml fractions were discarded, and the next
9 fractions (numbers 4 to 12) collected. Caveolin 3-enriched
caveolar membranes were concentrated in fractions 4 and 5.
Site-directed mutagenesis
Mutagenesis reactions were performed with the Quikchange
Lightning and Quikchange Multi Site-Directed Mutagenesis kits
(Agilent, Santa Clara, CA, USA). Individual cysteines were mu-
tated to alanines using the Quikchange Lightning Site-Directed
Mutagenesis Kit (Agilent). The mutagenesis primer pairs used
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were as follows: C383A: forward, CAAGGGACCTATCAGGCTCT-
GGAGAACTGTGGG, reverse, CCCACAGTTCTCCAGAGCCTG-
ATAGCTCCCTTG; C387A: forward, CAGTGTCTGGAGAACGC-
TGGGACTGTAGCCC, reverse, GGGCTACAGTCCCAGCGTTC-
TCCAGACACTG; C383A/C387A: forward, GGGACCTATCAG-
GCTCTGGAGAACGCTGGGACTGTAGCC, reverse, GGCTACA-
GTCCCAGCGTTCTCCAGAGCCTGATAGGTCCC; C485A:
forward, GTTTCTGCGCTCGCTGCCCTGGGATCTCCC, reverse,
GGGAGATCCCAGGGCAGCGAGCGCAGAAAC; C557A: for-
ward, GGACTTTGAGGACACTGCTGGAGAGCTCGAATTCC,
reverse, GGAATTCGAGCTCTCCAGCAGTGTCCTCAAAGTCC;
C731A: forward, GATGATGACGACGATGAAGCTGGAGAG-
GAGAAGCTG, reverse, CAGCTTCTCCTCTCCAGCTTCATC-
GTCGTCATCATC; C739A: forward, GGAGAAGCTGCCCTC-
CGCTTTCGATTATGTGATGC, reverse, GCATCACATAATC-
GAAAGCGGAGGGCAGCTTCTCC; C914A: forward, CAAGC-
TCCTCACATCCGCCCTCTTCGTGCTCCTATG, reverse,
CATAGGAGCACGAAGAGGGCGGATGTGAGGAGCTTGG.
A cys-lessNCX1 intracellular loop (cysteines 383, 387, 485, 557,
731, 739 all mutated to alanine) was created using the Quik-
change Multi Site-Directed Mutagenesis Kit, which requires for-
ward primers only. The same mutagenesis reaction also yielded
all other mutants described.
RESULTS
NCX1 is palmitoylated in cardiac muscle, brain,
and kidney
Analysis of the rat neural palmitoyl proteome has pre-
viously identiﬁed NCX1 andNCX2 as being palmitoylated
(38), but did not address whether a biologically meaningful
fraction of NCX was modiﬁed. We puriﬁed palmitoylated
proteins using resin-assisted capture of acylated proteins
(acyl-RAC) from homogenates of rat brain, kidney, and
heart (Fig.1A).NCX1was robustlypalmitoylated inall tissues
examined, implying that multiple splice variants are palmi-
toylated. We determined what fraction of the cardiac splice
variant NCX1.1 is palmitoylated in isolated rat ventricular
myocytes by comparing the enrichment of NCX1 following
acyl-RAC with the enrichment of the stoichiometrically pal-
mitoylated protein caveolin 3 (39). A small fraction ofNCX1
was not puriﬁedby acyl-RAC, but all caveolin 3was captured.
The results indicate that;60% of NCX1 is palmitoylated in
ventricular muscle (Fig. 1B). We also conﬁrmed palmitoy-
lation of NCX1.1 in human-induced pluripotent stem cells
differentiated into cardiac myocytes (Fig. 1C).
Identiﬁcation of the NCX1 palmitoylation site
To identify the site of palmitoylation in NCX1, individual
cysteines predicted to reside in or close to the cytoplasmic
domains (see currently accepted topology, Fig. 2A) were
mutated to alanine in the NCX1.1 canine cDNA, then
expressed inHEK (Fig. 2B) andHeLa (not shown) cells. All
cysteine-to-alanine mutants investigated displayed similar
palmitoylation to WT NCX1 with the exception of mutant
C739A, in which palmitoylation was abolished, strongly
suggesting that this is the sole siteofpalmitoylation inNCX1.
To conﬁrm that the presence of C739 is necessary and
sufﬁcient for palmitoylation of NCX1 we engineered a cys-
less NCX1 in which all cysteines in the large intracellular
loop were mutated to alanine. Individual cysteines were
added back to the intracellular loop, and palmitoylation was
assessed by acyl-RAC following expression in HEK (Fig. 2C)
and HeLa (not shown) cells. NCX1 was only palmitoylated
when C739 was present.
Impact of palmitoylation on NCX1 trafﬁcking and
subcellular localization
The pharmacological speciﬁcity of 2-bromopalmitate,
widely used as an inhibitor of Asp-His-His-Cys motifs con-
taining palmitoyl acyl transferases, has recently been
questioned (40). We therefore used both genetic and
pharmacological approaches to assess the impact of pal-
mitoylation on trafﬁcking of NCX1 through the secretory
pathway in FT-293 cells stably expressing WT and C739A
NCX1. Neither 2-bromopalmitate (100 mM, applied over-
night) nor mutation C739A inﬂuenced cell surface locali-
zation of NCX1 (assessed using membrane impermeable
amine-reactive biotinylation reagents, Fig. 3A).
We next investigated the subcellular compartment in
which NCX1 is palmitoylated and the consequences of
palmitoylation by using a YFP fusion protein of the YFP-
NCX1-IC. WT, cys-less, and C739only loops fused to the C
TABLE 1. Compositions of solutions in electrophysiology experiments
Ingredient
Fig. 4A Fig. 4B Fig. 5A Figs. 5B and 7 Fig. 6
Pipette Bath Pipette Bath Pipette Bath Pipette Bath Pipette Bath
NaOH (mM) 40 70 0 120 or 0 40 70 40 0 40 120
LiOH (mM) 0 0 0 0 or 120 0 0 0 0 0 0
NMDG (mM) 85 70 120 0 85 70 85 120 85 0
TEA-OH (mM) 15 10 15 10 15 10 15 20 15 15
HEPES (mM) 15 10 15 10 15 10 15 10 15 10
EGTA (mM) 20 0.5 20 0.5 20 0.5 0.5 or 10 0.5 10 0.5
CaCO3 (mM) 2 or 10 0 10 or 18 0 0 0 0 0 0
CaCl2 (mM) 0 0 or 4 0 0 0 0 or 4 0.25 or 1 0 or 4 1 0 or 4
MgCl2 (mM) 0.5 4 or 0 0.25 4 0.25 4 or 0 0.5 4 or 0 0.5 4
MgATP (mM) 8 0 8 0 8 0 0 0 0 0
TrisATP (mM) 2 0 2 0 2 0 0 0 0 0
Asp to pH (mM) 7.0 7.4 7.0 7.4 7.0 7.4 7.0 7.4 7.0 7.4
AlCl3 (mM) 0 0 0 0 0 0 0 0 0.15 0
Free pipette Ca (mM) 0.1 or 0.5 0.5 or 3.0 0 0.5 or 0.1 0.1
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terminusof YFPwere expressedby transient transfection in
HEK cells. We used a simple fractionation protocol based
on detergent solubility to prepare cytosolic (digitonin solu-
ble), membrane (Triton X-100 soluble), and insoluble frac-
tions. Cys-less YFP-NCX1-IC was entirely cytosolic (Fig. 3B),
whereas WT and C739only loops were found in both cyto-
solic and membrane fractions, indicating that the pres-
ence of the palmitoylation site at C739 was sufﬁcient to
provide a membrane anchor in the absence of NCX1
transmembrane domains. The subcellular location of all 3
loops and their colocalization with ﬂuorescent endoplas-
mic reticulum (DsRed-ER, Fig. 3C) and Golgi (Grasp65-
mCherry, Fig. 3D) marker proteins were also investigated.
The subcellular distribution of cys-less YFP-NCX1-IC es-
sentially matched YFP alone, whereas WT and C739only
loops were localized to punctate intracellular structures
that colocalized with a Golgi but not an endoplasmic re-
ticulum marker.
Palmitoylation is proposed to partition proteins to
detergent-resistant membranes such as caveolae (41), so
we investigated localization of NCX1 to cardiac caveolae.
NCX1 is reported to localize tocaveolaeby somebutnot all
researchers (42, 43). We found that NCX1 robustly local-
izes to buoyant caveolin-enrichedmicrodomains prepared
from rat ventricular myocytes using a standard discontin-
uous sucrose gradient (Fig. 3E). Buoyant (pooled fractions
Figure 2. Identiﬁcation of the NCX1 palmitoylation site. A)
Membrane topology of mature NCX1.1 following cleavage of
the signal peptide. The start and end of the large intracellular
loop, and positions of the mutated cysteines are numbered. B)
Individual cysteines and pairs of cysteines were mutated to
alanine and transiently expressed in HEK cells. All mutants
were palmitoylated with the exception of C739A. All acyl-RAC
reactions were blotted for ﬂotillin 2 (Flot2) to conﬁrm
efﬁcient puriﬁcation of palmitoylated proteins. C) Individual
cysteines were reintroduced to NCX1 with a cys-less in-
tracellular loop (cysteines 383, 387, 485, 557, 731, and 739 all
mutated to alanine). Palmitoylation of NCX1 requires the
presence of C739 only. M, mock transfected; Palm, proteins
puriﬁed using acyl-RAC; RVM, rat ventricular myocytes; UF,
unfractionated cell lysate.
Figure 1. NCX1 is palmitoylated in heart, brain and kidney. A)
Palmitoylated proteins were puriﬁed from homogenates of
heart, brain, and kidney and immunoblotted as shown. Note
the extended incubation at 40°C during acyl-RAC causes
partial aggregation of NCX1 resulting in 2 species of ;120
and 150 kDa resolved by SDS-PAGE. B) Fraction of NCX1.1
palmitoylated in ventricular muscle. A small fraction of
NCX1.1 is not palmitoylated in ventricular muscle. NCX1.1
enrichment in acyl-RAC reactions was normalized to the
constitutively palmitoylated protein caveolin 3 (Cav3). n = 5,
mean 6 SEM shown. C) NCX1.1 is palmitoylated in human-
induced pluripotent stem cells differentiated into cardiac
myocytes. P, proteins puriﬁed by acyl-RAC; Palm, proteins
puriﬁed using acyl-RAC in either the presence (+) or absence
(2) of hydroxylamine (ha); UF, unfractionated cell lysate;
UB, material not captured by acyl-RAC.
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Figure 3. Impact of palmitoylation on NCX1 trafﬁcking and subcellular localization. A) Neither pharmacological nor genetic inhibition
of NCX1 palmitoylation alters cell surface expression of NCX1 in stably transfected FT-293 cells (2-BP, 100 mM, applied overnight). B)
Fractionation based on detergent solubility indicates YFP-NCX1-IC is membrane-anchored when palmitoylated in transiently transfected
HEK cells. C) Subcellular distribution of YFP-NCX1-IC in transiently transfected HEK cells. Cys-less YFP-NCX1-IC is distributed similar to
YFP alone. WT and C739only YFP-NCX1-IC localize to an intracellular compartment but do not colocalize with the endoplasmic
reticulum marker DsRed-ER. D) WT and C739only YFP-NCX1-IC colocalize with the Golgi marker Grasp65-mCherry in transiently
transfected HEK cells. E) NCX1 localizes to buoyant caveolin enriched microdomains in rat ventricular myocytes. F) Both palmitoylated
and nonpalmitoylated NCX1 are present in buoyant caveolin enriched microdomains prepared from rat ventricular myocytes. 2-BP,
2-bromopalmitate; CS, cell surface protein; SM, starting cell lysate.
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4 and 5) and dense (pooled fractions 8–12) membranes
were used in acyl-RAC experiments to separate palmitoy-
lated from nonpalmitoylated proteins (Fig. 3F). Although
the majority of NCX1 localizes to buoyant membranes in
rat ventricular myocytes, we found both palmitoylated and
nonpalmitoylated NCX1 in these membranes, suggesting
thatpalmitoylation isnot required for localizationofNCX1
to cardiac caveolae.
Functional effect of palmitoylation on NCX1
We used whole cell voltage clamp of FT 293 cells stably
expressingWT andC739ANCX1 to determine the impact
of palmitoylation on NCX1 function (Fig. 4). Using cyto-
plasmic solutions that were heavily Ca-buffered, outward
NCX1 currents (activated by the application of 4 mM ex-
tracellular Ca) were measured in the presence of both 0.1
and 0.5 mM free intracellular Ca (Fig. 4A). Inward NCX1
currents (activated by the application of 120 mM extra-
cellular Na in exchange for Li) were measured in the
presenceof 0.5 and3mMfree intracellularCa(Fig. 4B).No
quantitative or qualitative differences in either outward or
inward exchanger currents were identiﬁed between cells
expressing WT and C739A NCX1.
Palmitoylation and NCX1 inactivation
NCXs contribute a substantial proportion of Na load in
cardiac muscle, and Na-dependent inactivation of NCXs
may decrease myocyte Na load during metabolic stress as
part of a cell program to shift Ca turnover to internal
recycling and away from turnover across the sarcolemma
(44). We measured the impact of palmitoylation on the
transition of NCX1 to inactivated states by inducing in-
activation in 4 different ways (Figs. 5 and 6). First, com-
plete chelation of cytoplasmic Ca completely inactivates
NCX1, probably because Ca binding to CBDs in the NCX1
large intracellular loop antagonizes Na-dependent in-
activation (45). Using 20 mM EGTA without added Ca on
the cytoplasmic side, exchange currents declined over the
course of 4 min to negligible values in cells expressing WT
exchangers but to 22% of initial values in cells expressing
C739A exchangers (Fig. 5A, P , 0.05). Second, in the ab-
sence of intracellular ATP, a large Ca transient inactivates
NCX1 by causing depletion of PIP2, through the activity of
PLCs (46). In this case, a single large Ca transient (induced
by activating reverse exchange current in the presence of
a low intracellular EGTA concentration), results in .90%
inactivation of NCX1 current at subsequent activation epi-
sodes (Fig. 5B). This nearly complete inactivation was
Figure 4. Effect of palmitoylation on NCX1 function. Stably transfected FT-293 cells expressing WT and C739A NCX1 were
voltage clamped in the whole-cell mode. Current traces are shown in red, capacitance traces in blue, changes in extracellular
solution indicated in green, and changes in pipette solution in pink. A) Outward NCX1 currents in the presence of both 0.1 and
0.5 mM intracellular Ca were activated by stepping extracellular Ca from 0 to 4 mM in cells expressing WT (left) and C739A
exchangers (center). No differences in outward exchanger current were observed in WT or nonpalmitoylatable NCX1 (right). B)
Inward NCX1 currents in the presence of both 0.5 and 3 mM intracellular Ca were activated by the application of 120 mM
extracellular Na in exchange for Li in cells expressing WT (left) and C739A exchangers (center). No differences in inward
exchanger currents were observed in WT or nonpalmitoylatable NCX1 (right). Current transients that occur during the
activation of inward currents by extracellular Na likely reﬂect cytoplasmic Ca depletion, namely because the buffer capacity of
EGTA is weak when it is nearly saturated with Ca to generate 3 mM free Ca.
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reduced to ,30% in cells expressing C739A NCX1 (P ,
0.01).We thereforeconclude thatpalmitoylation facilitates
and may be required for complete inactivation of NCX1
by both removal of cytoplasmic Ca and by loss of PIP2.
As a means to cause inactivation of NCX1 without chang-
ing cytoplasmic free Ca, we included polylysine in ATP-free
cytoplasmic solutions to bind anionic phospholipids prior to
activation of exchange current by Ca (47). Figure 6A shows
results with 20 mM heptalysine added to cytoplasmic solu-
tions. The initial exchange current activated by extracellular
Ca in cells expressing WT exchangers is decreased by more
than 50% from those in Fig. 5, and current decays within
seconds to negligible values during application of extracel-
lular Ca. The average currents in cells expressing C739A-
mutant exchangers decline substantially less theWTcurrents
(P, 0.01) to about 30% of peak currents.
Finally, we exploited that fact that EGTA/aluminum
chelates effectively provide Al3+ to bind to PIP2 head
groups with extraordinarily high afﬁnity, thereby masking
PIP2 head groups in a speciﬁc manner (27). Using ATP-
free pipette solutionswith 10mMEGTAand0.15mMAl3+,
the steady-state exchange currents in WT-expressing cells
are reduced to0.8160.5pAmp/pFarad (;10%of routine
values), and currents obtained in C739A-expressing cells
are 4-fold greater (3.7 pAmp/pFarad, P , 0.01; nearly
50% of routine values). Therewith, results from 4 different
experimental protocols concur that inactivation ofNCX1 is
decreased by the C739A mutation.
NCX1 palmitoylation and membrane endocytosis
Given that palmitoylation does not affect exchanger ocaliza-
tion in HEK cells, we tested whether NCX1 palmitoylation
might affect endocytosis by adapter-independent mecha-
nisms that can occur during cell stress in a palmitoylation-
dependent manner (48). Speciﬁcally, it has been dem-
onstrated for Na/K pumps that palmitoylation of
the accessory subunit phospholemman can promote
adapter-independent endocytosis that is enhanced by
overexpression of phospholemman and therefore is
cargo-dependent (49). InFig. 7, we employed 2protocols
that result in endocytosis of about 50%of the cell surface,
and in both protocols the C739A mutation strongly
decreases endocytosis monitored as a loss of membrane ca-
pacitance. In Fig. 7A we describe that the nonhydrolyzable
GTP analog, GTPgS, activates massive endocytosis in WT-
expressing cells with free cytoplasmicCaclamped to0.1mM.
Clearly,G-proteinactivationcanpowerfullypromoteadapter-
independent endocytosis (50) when: 1) clathrin is blocked
by potassium-free cytoplasmic solutions (36); 2) the GTP-
hydrolyzing endocytic protein, dynamin, is inhibited by
Figure 5. Effect of palmitoylation on NCX1 inactivation by Ca depletion and excess. Stably transfected FT-293 cells expressing WT
and C739A NCX1 were voltage clamped in the whole-cell mode. Current traces are shown in red, capacitance traces in blue, and
changes in extracellular Ca indicated in green. Outward NCX1 currents were activated by stepping extracellular Ca from 0 to
4 mM in cells expressing WT (left) and C739A exchangers (center). A) Effect of removal of intracellular Ca with EGTA. NCX1
inactivation is signiﬁcantly slower in C739A NCX1 compared with WT: 240 s after application of EGTA a signiﬁcantly greater
current remains in cells expressing C739A NCX1 (right). *P , 0.05 vs. WT. B) Effect of PIP2 depletion by a large Ca transient in
the absence of intracellular ATP. In this protocol, the magnitude of the initial NCX1 current remains stable for periods of many
minutes although the cytoplasmic ATP concentration is nominally zero. The initial activation cycle results in complete NCX1
inactivation in WT but not C739A-expressing cells (right). **P , 0.01 vs. WT.
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GTPgS (51); and 3) palmitoylated NCX1 exchangers are
highly expressed in the surface membrane. As shown in
Fig. 7A, fully 50% of cell area is lost within 3 min when
WT-expressing cells are opened with the Ca-buffered,
GTPgS-containing pipette solution. Although nearly the
same amount of membrane is lost in C739 mutant cells
over time, the rate of membrane loss is decreased by
more than 3-fold (Fig. 7B, P , 0.01). This form of en-
docytosis is strongly cargo-dependent, as illustrated by
the near absence of endocytosis in FT-293 cells express-
ing no exchangers (Fig. 7A, dotted line). As shown in Fig.
7C using a cytoplasmic solution with low Ca buffering
power, more than 50% of cell membrane is also lost via
Ca-dependent endocytosis when NCX-expressing cells
are exposed to extracellular ionomycin andCa. The time
required to remove 30% of the cell surface (Fig. 7D) was
increased from 19 s in WT-expressing cells to 31 s in
C739A-expressing cells and to 38 s in FT-293 cells that do
not express exchangers. In conclusion, these results
demonstrate by 2 protocols that overexpression of NCX1
promotes adapter-independent endocytosis and that
NCX1 palmitoylation further promotes this form of en-
docytosis, presumably by promoting the formation of
lipid–protein domains in the cell surface.
DISCUSSION
In thisarticle,wehavedocumented thatNCX1is substantially
palmitoylated in cardiac muscle. Nonpalmitoylatable mu-
tant exchangers do not inactivate fully when cytoplasmic
Ca is chelated or when the negative charges of anionic
phospholipids are neutralized. In addition, the ability
of exchangers to promote adapter-independent, cargo-
dependent endocytosis is substantively decreased in
a nonpalmitoylatable NCX1mutant. Notably, this mutant
still localizes to the surface membrane and functions in
a nominally normal fashion. Thus, palmitoylation tunes
NCX function in only a subset of cellular circumstances,
Figure 6. Effect of palmitoylation on NCX1 inactivation by
masking anionic phospholipid head groups. Stably transfected
FT-293 cells expressing WT and C739A NCX1 were voltage
clamped in the whole-cell mode using ATP-free, highly Ca-
buffered cytoplasmic solutions (10 mM EGTA with 1 mM Ca).
A) Using a cytoplasmic solution containing 20 mM heptalysine
(K7) to bind head groups of anionic phospholipids, outward
exchange currents were activated by stepping extracellular Ca from
0 to 4 mM in cells expressing WT (left) and C739A exchangers
(right). Current magnitudes are given for peak currents and
current remaining after 10 s. Residual currents are highly
signiﬁcantly increased in cells expressing C739A compared with
WT exchangers. B) Using a cytoplasmic solution containing
0.15 mM Al3+ (in the presence of 10 mM EGTA) to bind PIP2
head groups, outward exchange currents were strongly sup-
pressed in cells expressing WT exchangers (left) but remained
robust in cells expressing C739A exchangers (right). **P, 0.01.
Figure 7. Impact of palmitoylation of NCX1 on massive
endocytosis occurring in response to excessive G-protein activa-
tion and Ca inﬂux. Stably transfected FT-293 cells expressing WT
and C739A NCX1 were voltage clamped in the whole-cell
mode with 8 mM MgATP in the pipette solution. A) Using
a highly Ca-buffered cytoplasmic solution (10 mM EGTA with
1 mM Ca) with 0.25 mMGTPgS, cells expressing WT exchangers
internalize 336 3% of their membrane within 40 s of establishing
the whole cell conﬁguration, whereas cells expressing C739A
exchangers internalize only 10 6 2%. (P , 0.001). At 3 min,
the difference between exchanger-expression cells is not signiﬁ-
cant, and membrane loss in cells without exchangers is negligible.
B) Quantitation of endocytosis as the time required to decrease
membrane area by 30%. C739A-expressing cells internalize at
a rate that is .3 times less than cells expressing WT exchangers.
C) Using a weakly Ca-buffered cytoplasmic solution (0.5 mM
EGTA with 0.25 mM Ca), extracellular Ca (2 mM) is applied
with 7 mM ionomycin to promote Ca inﬂux. In WT-expressing
cells, small initial exocytic responses (i.e., with increasing
membrane area) are followed by loss of 50% of the cell
surface within about 20 s. In C739 cells, the exocytic responses
are larger and endocytic responses are delayed. The loss of
membrane area in cells expressing WT exchangers amounts
to 33 6 4%, and loss of membrane in C739A-expressing cells
amounts to only 13 6 6% (P , 0.01). D) Quantitation of Ca-
induced endocytic responses as the time required to remove
30% of the cell surface. Endocytosis times are increased by
.50% in C739A cells, compared with WT cells (P , 0.05),
and endocytosis times are doubled in cells that do not express
NCX1 (P , 0.01). *P , 0.05, **P , 0.01, ***P , 0.001.
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speciﬁcally circumstance of cell stress in which exchanger
function can be pivotal for cell survival or demise. Palmi-
toylation occurs early in the lifetime of NCX1, so we hy-
pothesize that depalmitoylation provides a mechanism to
regulate exchanger function after insertion into the cell
surface, as well as to regulate its removal from the cell
surface in cell stress.
Functional effects of palmitoylation
NCX is regulated by both ions it transports via reactions that
involve its large intracellular loop. Ca-dependent activation is
mediated by two CBDs: Ca binding to CBD1 (residues
361–461)withhigh(,1mM)afﬁnityactivates theexchanger,
and Ca binding to CBD2 (residues 492–592) with lower af-
ﬁnity relievesNa-dependent inactivation(47).Na-dependent
inactivation requires the XIP region of the intracellular loop
(residues 219–238) (52) and is reversed by Mg-ATP–
dependent synthesis of PIP2 (27, 53). Inhibition by XIP is
proposed to involve a direct interaction between XIP and
residues 562–679, within CBD2 (54). NCX1 in our engi-
neeredcell lines is activatedby cytoplasmicCawith veryhigh
Ca afﬁnity, similar to NCX1 in intact cardiac myocytes (55),
and in contrast to results for excisedmembrane patches, in
which 1 log unit higher free Ca is required to activate the
outward exchange current (56).
We observed no difference in the activities of WT and
unpalmitoylatable exchangers when examined with free
cytosplasmicCabuffered to0.1mMorgreater.We therefore
suggest that the functional effectofpalmitoylationonNCX1
inactivation is achieved through an inﬂuence on the in-
teraction between XIP and the intracellular loop. Unpal-
mitoylatable NCX1 does not inactivate following PIP2
depletion or chelation, so palmitoylation at C739 seems to
be required for the XIP domain to fully inhibit exchange
activity. One possibility is that palmitoylation enhances the
propensity of anionic lipids to bind the XIP domain and
thereby prevent it from inactivating exchange activity.
The extent of NCX palmitoylation varies depending on
the cell type examined, being most robust in ventricular
myocytes and least robust in cultured cells (Supplemental
Fig. 1). The extent ofNa-dependent inactivation also varies
signiﬁcantly in different experimental models (53, 57).
Therefore, the physiologic roles of Na-dependent inactiva-
tionand its relief byPIP2have remainedenigmatic (44).Our
data suggest that these disparities may reﬂect differences in
the extent of NCX1 palmitoylation in the different models,
caused by differences in acyl transferase or thioesterase ex-
pression or activity in different cell types. Palmitoylation is
clearly not required for trafﬁcking of NCX1, so cell surface
localized nonpalmitoylated NCX1 has likely been studied in
a number of investigations. As well as displaying prominent
Na-dependent inactivation, squid NCX1 in giant axon
preparations was extensively characterized in a number of
classic early studies on the regulation ofNCX1 (58). Notably
the NCX1 palmitoylation site is conserved in some inverte-
brates, including squid (discussed below).
AlthoughX-ray andNMR structures of CBD1andCBD2
in the NCX1 large intracellular loop have been obtained
(59), no structural information currently exists about the
region of this loop containing the palmitoylation site. Dis-
order and secondary structure prediction algorithms (not
shown) indicate that Cys739 (but not the neighboring
Cys731) lies in anordered regionof this loop(60), but that it
is less than 25% solvent exposed (61), suggesting that weak
membrane association may precede its palmitoylation.
Palmitoylation regulates multiple NCX1 interactions
with the surface membrane
The presence of a membrane anchor at position C739 can
be expected to inﬂuence the tilt of multiple interacting
transmembrane domains in NCX1 (52). Transitions be-
tween outward- and inward-facing conﬁrmations of a bac-
terial NCXhomolog are proposed to requiremovement of
the loosely packedhelices transmembranedomains 1 and6
(21). It is rather surprising therefore that the normal
function of NCX1 is not more markedly modiﬁed by the
palmitoylation at C739. Rather, our work suggests that
palmitoylation changes primarily the relationship of NCX1
to the lipid bilayer with consequences for NCX1 regulation
and participation in membrane domains. Speciﬁcally, the
full inactivation of NCX upon depletion of cytoplasmic Ca,
by nonspeciﬁc masking of anionic phospholipids, by de-
pletionofPIP2, andby speciﬁcmaskingofPIP2headgroups
(Figs. 5 and 6) all require NCX palmitoylation. Thus it is
likely that unpalmitoylatable NCX1 is active in PIP2-free
intracellular membrane compartments but WT NCX1 is
not. Potentially, the complete inactivation of NCX during
its processing and trafﬁcking preventsNCX fromdepleting
Ca gradients in internal membrane compartments where
Na gradients are small or minimal (62). Hence, NCX in-
activation as a result of its palmitoylation in the Golgi ap-
paratus may preserve this intracellular Ca store (63). That
said, we foundno inﬂuence of unpalmitoylatableNCX1on
cell growth rates or on expression of markers of endoplas-
mic reticulum stress (Supplemental Fig. 2). This effect of
palmitoylation on lipid regulation of an ion transporter
bears similarities to the regulation of the sodium pump by
its palmitoylated accessory subunit phospholemman,
which appears to rely on palmitoylation of phospho-
lemman modulating regulatory lipid interactions with
the pump (35, 64). A large number of ion channels and
transporters are regulated by PIP2, as well as other
phospholipids (65), and a similarly large number are also
palmitoylated (34). As the only reversible lipid modiﬁ-
cation, palmitoylation may provide a means to reversibly
sensitize channels and transporters to regulation by their
phospholipid environment.
In addition tomodulating the immediate interactions of
NCX1transporterswithphospholipids, our results indicate
that palmitoylation of NCX1 promotes its participation in
membrane domains that can be internalized in a cargo-
dependent manner without involvement of classic endo-
cytic proteins (36). These results conﬁrm that palmitoyla-
tion can promote membrane protein/lipid phase
separations whereby more ordered domains can be
preferentially internalized in many cell types (48). Cells
expressing the C739A exchanger mutant have similar
exchange activities as those expressing WT NCX1, and
cell surface areas are not impressively changed, so it is
unlikely that this form of endocytosis is occurring con-
stitutively in the cells employed in this study. The most
obvious situation in which this form of endocytosis will
play a major role inmuscle is the response of myocytes to
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Ca overload. However, the fact that equally large endocytic
responses can occur in the absence of Ca transients, namely
when G proteins are highly activated by GTPgS (Fig. 7A),
suggests that other types of cell stress can also activate these
endocytic processes to dramatically remodel the cell surface.
Palmitoylation of other members of the cation/Ca2+
exchanger superfamily
NCX1isamemberof thecation/Caexchanger superfamily,
which is deﬁned by the presence of highly conserved
a-repeat regions within 2 membranous hydrophobic
domains, which are separated by a hydrophilic cytosolic
loop rich in acidic amino acids. This superfamily of 147
transporters from both eukaryotes and prokaryotes consists
of 5 distinct protein families (66). We used Clustal Omega
(67) to align the hydrophilic regions of representative
members (mammalian, where available) of each family
(Fig. 8A); the palmitoylated cysteine in NCX1 is not found
in the other mammalian family members (Na/K/Ca
exchangers or the mitochondrial exchanger NCLX), or in
the H/Ca exchanger or YRBG families. No homologous
position exists in the crystallized NCX homolog NCX_Mj,
which is short (7 amino acids) and disordered (21).
Alignment of NCX family members (Fig. 8B) indicates
the NCX1 palmitoylated cysteine (and some other local se-
quence features) is conservedamongallNCX isoforms inall
vertebrates, as well as squid and the Drosophila exchanger
Calx, but it is only present in NCX2 from Caenorhabditis
elegans. We therefore suggest that this palmitoylation site is
an adaptation in vertebrates and higher invertebrates to
regulate NCX activity.
CONCLUSIONS
Although palmitoylation of NCX1 in its large intracellular
loop occurs in the secretory pathway, it is surprisingly not
required for NCX trafﬁcking or function in our HEK
overexpression system. Palmitoylation regulates NCX1 in-
activation,possibly inﬂuencing theability of theXIP region
to inhibit exchanger activity, and palmitoylation promotes
the participation of NCX1 inmembrane domains that can
be internalized in a cargo-dependent fashion.
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